Literature DB >> 29995047

Redox-responsive cisplatin nanogels for anticancer drug delivery.

Weiqi Zhang1, Ching-Hsuan Tung.   

Abstract

Inspired by cisplatin's deactivation by glutathione (GSH) in cancer, a GSH responsive nanogel loaded with doxorubicin (Dox) was prepared using hyaluronan as a matrix and cisplatin as a crosslinker. The elevated GSH depletes the cisplatin crosslinker in the nanogel, enhances Dox release and boosts cytotoxicity, thus providing a new GSH responsive platform to reverse cisplatin resistance.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29995047      PMCID: PMC6057802          DOI: 10.1039/c8cc01795f

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  29 in total

1.  A molecular view of cisplatin's mode of action: interplay with DNA bases and acquired resistance.

Authors:  M Paula M Marques; Diego Gianolio; Giannantonio Cibin; John Tomkinson; Stewart F Parker; Rosendo Valero; R Pedro Lopes; Luis A E Batista de Carvalho
Journal:  Phys Chem Chem Phys       Date:  2015-02-21       Impact factor: 3.676

2.  Differences in cisplatin distribution in sensitive and resistant ovarian cancer cells: a TEM/NanoSIMS study.

Authors:  Ronald F S Lee; Tina Riedel; Stéphane Escrig; Catherine Maclachlan; Graham W Knott; Curt A Davey; Kai Johnsson; Anders Meibom; Paul J Dyson
Journal:  Metallomics       Date:  2017-10-18       Impact factor: 4.526

3.  Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels.

Authors:  Periannan Kuppusamy; Haiquan Li; Govindasamy Ilangovan; Arturo J Cardounel; Jay L Zweier; Kenichi Yamada; Murali C Krishna; James B Mitchell
Journal:  Cancer Res       Date:  2002-01-01       Impact factor: 12.701

4.  Cisplatin Cross-Linked Multifunctional Nanodrugplexes for Combination Therapy.

Authors:  Weiqi Zhang; Ching-Hsuan Tung
Journal:  ACS Appl Mater Interfaces       Date:  2017-03-01       Impact factor: 9.229

5.  Microenvironmental InterFereNce of metabolism regulates chemosensitivity.

Authors:  Leila Akkari; Johanna A Joyce
Journal:  Cell Res       Date:  2016-06-28       Impact factor: 25.617

Review 6.  Glutathione in cancer biology and therapy.

Authors:  José M Estrela; Angel Ortega; Elena Obrador
Journal:  Crit Rev Clin Lab Sci       Date:  2006       Impact factor: 6.250

Review 7.  Cisplatin resistance and opportunities for precision medicine.

Authors:  Lauren Amable
Journal:  Pharmacol Res       Date:  2016-01-22       Impact factor: 7.658

Review 8.  The resurgence of platinum-based cancer chemotherapy.

Authors:  Lloyd Kelland
Journal:  Nat Rev Cancer       Date:  2007-07-12       Impact factor: 60.716

9.  Spectrophotometric determination of platinum with o-phenylenediamine.

Authors:  E D Golla; G H Ayres
Journal:  Talanta       Date:  1973-02       Impact factor: 6.057

10.  Human cancer-associated fibroblasts enhance glutathione levels and antagonize drug-induced prostate cancer cell death.

Authors:  Emarndeena H Cheteh; Martin Augsten; Helene Rundqvist; Julie Bianchi; Victoria Sarne; Lars Egevad; Vladimir Jn Bykov; Arne Östman; Klas G Wiman
Journal:  Cell Death Dis       Date:  2017-06-01       Impact factor: 8.469

View more
  6 in total

1.  Therapeutic polymeric nanomedicine: GSH-responsive release promotes drug release for cancer synergistic chemotherapy.

Authors:  Jie Shen; Qiwen Wang; Jie Fang; Wangxing Shen; Dan Wu; Guping Tang; Jie Yang
Journal:  RSC Adv       Date:  2019-11-15       Impact factor: 4.036

2.  Hypoxia-degradable and long-circulating zwitterionic phosphorylcholine-based nanogel for enhanced tumor drug delivery.

Authors:  Shaojun Peng; Boshu Ouyang; Yongjie Xin; Wei Zhao; Shun Shen; Meixiao Zhan; Ligong Lu
Journal:  Acta Pharm Sin B       Date:  2020-08-26       Impact factor: 11.413

3.  Cu2+-Chelating Mesoporous Silica Nanoparticles for Synergistic Chemotherapy/Chemodynamic Therapy.

Authors:  Yanyan Zhang; Jiadong Lou; Gareth R Williams; Yuhan Ye; Dandan Ren; Anhua Shi; Junzi Wu; Wenling Chen; Li-Min Zhu
Journal:  Pharmaceutics       Date:  2022-06-04       Impact factor: 6.525

Review 4.  Nanomedicines for Overcoming Cancer Drug Resistance.

Authors:  Tingting Hu; Hanlin Gong; Jiayue Xu; Yuan Huang; Fengbo Wu; Zhiyao He
Journal:  Pharmaceutics       Date:  2022-08-01       Impact factor: 6.525

Review 5.  Preparation and use of nanogels as carriers of drugs.

Authors:  Cuixia Li; Sreekanth Reddy Obireddy; Wing-Fu Lai
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

Review 6.  Self-Assembled Nanogels Based on Ionic Gelation of Natural Polysaccharides for Drug Delivery.

Authors:  Huimin Wang; Hong Deng; Menghan Gao; Weiqi Zhang
Journal:  Front Bioeng Biotechnol       Date:  2021-07-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.